Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-28T20:38:47.271Z Has data issue: false hasContentIssue false

Dose and effect in CBT for schizophrenia

Published online by Cambridge University Press:  02 January 2018

Christian Gold*
Affiliation:
Uni Research Health, Bergen, Norway. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Type
Columns
Copyright
Copyright © Royal College of Psychiatrists, 2015 

Many thanks to Jauhar and colleagues for their interesting and thought-provoking review of cognitive–behavioural therapy (CBT) for schizophrenia, Reference Jauhar, McKenna, Radua, Fung, Salvador and Laws1 and especially for making their data publicly available. Previous discussants (Byrne, Reference Byrne2 McKenna et al Reference McKenna, Radua, Jauhar and Laws3 ) have commented on the lack of consideration given to ‘dose’ (i.e. number of sessions) of CBT. The relation between dose and effect is almost a classic in psychotherapy research. Reference Howard, Kopta, Krause and Orlinsky4 It has more recently been shown to be of importance in reviews of other psychosocial therapies (e.g. Gold et al Reference Gold, Solli, Krüger and Lie5 ). Together with the obvious plausibility of such a relationship, this seems to be enough reason to examine the dose–effect relation carefully. I used the effect sizes calculated by Jauhar et al and extracted the number of sessions from the original papers (I was able to do this for 32 of the 52 studies). I then ran a meta-regression (functions metagen and metareg from R package meta) for each of the four outcomes (Fig. 1). Most studies used between 10 and 20 sessions, with a few outliers in both directions. The regression lines show little support for an increase of effect with dose. On the contrary, there are tendencies in the opposite direction for all outcomes. The paradoxical observation is that effects seem to be strongest when few sessions were provided (significant for positive symptoms, P = 0.0005).

Fig. 1 Meta-regression for (a) total symptoms, (b) positive symptoms, (c) negative symptoms and (d) hallucinations.

Obviously this analysis has a number of limitations.

  1. (a) As McKenna et al Reference McKenna, Radua, Jauhar and Laws3 noted in their response to the comment by Byrne, Reference Byrne2 participants were not randomised to different doses.

  2. (b) Dose is likely confounded with duration Reference Gold6 and may also be confounded with masking and control interventions. Reference Jauhar, McKenna, Radua, Fung, Salvador and Laws1

  3. (c) There may be differences between the scheduled and the received dose, and this was not reported consistently in the original papers.

  4. (d) Dose data were not independently extracted by two people.

However, I think one can conclude from these analyses that dose is unlikely to have masked a clearer effect in these data. A more detailed re-analysis of this data-set may be warranted. In general, the dosage of psychotherapy should be considered carefully in future studies.

References

1 Jauhar, S, McKenna, PJ, Radua, J, Fung, E, Salvador, R, Laws, KR. Cognitive–behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry 2014; 204: 20–9.CrossRefGoogle ScholarPubMed
2 Byrne, RE. CBT for psychosis: not a ‘quasi-neuroleptic’. Br J Psychiatry 2014; 204: 489.Google Scholar
3 McKenna, PJ, Radua, J, Jauhar, S, Laws, KR. Authors' reply. Br J Psychiatry 2014; 204: 490.Google Scholar
4 Howard, KI, Kopta, SM, Krause, MS, Orlinsky, DE. The dose-effect relationship in psychotherapy. Am Psychol 1986; 41: 159–64.Google Scholar
5 Gold, C, Solli, HP, Krüger, V, Lie, SA. Dose-response relationship in music therapy for people with serious mental disorders: systematic review and meta-analysis. Clin Psychol Rev 2009; 29: 193207.Google Scholar
6 Gold, C. Quantitative psychotherapy outcome research: methodological issues. In Psychotherapy Research: Foundations, Process, and Outcome (eds OCG Gelo, A Pritz, B Rieken): 537–58. Springer, 2015.Google Scholar
Figure 0

Fig. 1 Meta-regression for (a) total symptoms, (b) positive symptoms, (c) negative symptoms and (d) hallucinations.

Submit a response

eLetters

No eLetters have been published for this article.